{"frames":[{"target":{"name":"Medical_specialties","spans":[{"start":3,"end":4,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.786008765826715,"frameElements":[{"name":"Type","spans":[{"start":2,"end":3,"text":"molecular"}]},{"name":"Specialty","spans":[{"start":3,"end":4,"text":"medicine"}]}]}]}],"tokens":["Trends","in","molecular","medicine","."]}
{"frames":[{"target":{"name":"Collaboration","spans":[{"start":5,"end":6,"text":"partners"}]},"annotationSets":[{"rank":0,"score":39.83354751984161,"frameElements":[{"name":"Partner_2","spans":[{"start":6,"end":8,"text":"in cancer"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":7,"end":8,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]}],"tokens":["EGFR","and","NF-kappa","B",":","partners","in","cancer","."]}
{"frames":[{"target":{"name":"Collaboration","spans":[{"start":2,"end":3,"text":"cooperate"}]},"annotationSets":[{"rank":0,"score":35.005416843808284,"frameElements":[{"name":"Undertaking","spans":[{"start":3,"end":17,"text":"to promote tumor development and progression by sustaining cell proliferation , survival and invasiveness"}]},{"name":"Partner_1","spans":[{"start":1,"end":2,"text":"proteins"}]}]}]},{"target":{"name":"Cause_change_of_position_on_a_scale","spans":[{"start":4,"end":5,"text":"promote"}]},"annotationSets":[{"rank":0,"score":60.243176005546864,"frameElements":[{"name":"Item","spans":[{"start":5,"end":17,"text":"tumor development and progression by sustaining cell proliferation , survival and invasiveness"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":5,"end":6,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Event","spans":[{"start":6,"end":7,"text":"development"}]},"annotationSets":[{"rank":0,"score":33.90876569584119,"frameElements":[{"name":"Event","spans":[{"start":5,"end":6,"text":"tumor"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":11,"end":12,"text":"cell"}]},"annotationSets":[{"rank":0,"score":16.010415802908028,"frameElements":[{"name":"Building_part","spans":[{"start":11,"end":12,"text":"cell"}]}]}]},{"target":{"name":"Proliferating_in_number","spans":[{"start":12,"end":13,"text":"proliferation"}]},"annotationSets":[{"rank":0,"score":76.10782652672752,"frameElements":[{"name":"Set","spans":[{"start":11,"end":12,"text":"cell"}]}]}]},{"target":{"name":"Surviving","spans":[{"start":14,"end":15,"text":"survival"}]},"annotationSets":[{"rank":0,"score":15.220875260370526,"frameElements":[]}]}],"tokens":["Oncogenic","proteins","cooperate","to","promote","tumor","development","and","progression","by","sustaining","cell","proliferation",",","survival","and","invasiveness","."]}
{"frames":[{"target":{"name":"Change_position_on_a_scale","spans":[{"start":2,"end":3,"text":"growth"}]},"annotationSets":[{"rank":0,"score":115.6807686140904,"frameElements":[]}]},{"target":{"name":"Contingency","spans":[{"start":3,"end":4,"text":"factor"}]},"annotationSets":[{"rank":0,"score":14.324714371253076,"frameElements":[{"name":"Determinant","spans":[{"start":2,"end":3,"text":"growth"}]}]}]},{"target":{"name":"Weapon","spans":[{"start":9,"end":10,"text":"nuclear"}]},"annotationSets":[{"rank":0,"score":64.70406760393467,"frameElements":[{"name":"Weapon","spans":[{"start":9,"end":10,"text":"nuclear"}]}]}]},{"target":{"name":"Contingency","spans":[{"start":10,"end":11,"text":"factor"}]},"annotationSets":[{"rank":0,"score":14.112799404013666,"frameElements":[{"name":"Determinant","spans":[{"start":10,"end":11,"text":"factor"}]}]}]},{"target":{"name":"Intentionally_act","spans":[{"start":17,"end":18,"text":"activities"}]},"annotationSets":[{"rank":0,"score":68.34970230753062,"frameElements":[{"name":"Act","spans":[{"start":9,"end":18,"text":"nuclear factor kappa b -LRB- NF-kappa B -RRB- activities"}]}]}]},{"target":{"name":"Perception_experience","spans":[{"start":19,"end":20,"text":"seen"}]},"annotationSets":[{"rank":0,"score":81.18494178386523,"frameElements":[{"name":"State","spans":[{"start":20,"end":24,"text":"in multiple solid tumors"}]},{"name":"Phenomenon","spans":[{"start":6,"end":18,"text":"EGFR -RRB- and nuclear factor kappa b -LRB- NF-kappa B -RRB- activities"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":21,"end":22,"text":"multiple"}]},"annotationSets":[{"rank":0,"score":24.37247372286268,"frameElements":[{"name":"Quantity","spans":[{"start":21,"end":22,"text":"multiple"}]},{"name":"Individuals","spans":[{"start":23,"end":24,"text":"tumors"}]}]}]},{"target":{"name":"Substance","spans":[{"start":22,"end":23,"text":"solid"}]},"annotationSets":[{"rank":0,"score":28.067401194179183,"frameElements":[{"name":"Substance","spans":[{"start":22,"end":23,"text":"solid"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":23,"end":24,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":35.52203376150035,"frameElements":[]}]},{"target":{"name":"Cause_to_amalgamate","spans":[{"start":25,"end":26,"text":"combine"}]},"annotationSets":[{"rank":0,"score":52.016405168566,"frameElements":[{"name":"Purpose","spans":[{"start":26,"end":33,"text":"to provide oncogenic signals to cancer cells"}]}]}]},{"target":{"name":"Supply","spans":[{"start":27,"end":28,"text":"provide"}]},"annotationSets":[{"rank":0,"score":65.84809386584844,"frameElements":[{"name":"Recipient","spans":[{"start":30,"end":33,"text":"to cancer cells"}]},{"name":"Theme","spans":[{"start":28,"end":30,"text":"oncogenic signals"}]}]}]},{"target":{"name":"Gesture","spans":[{"start":29,"end":30,"text":"signals"}]},"annotationSets":[{"rank":0,"score":32.14966879526895,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":31,"end":32,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":32,"end":33,"text":"cells"}]},"annotationSets":[{"rank":0,"score":20.022993225731557,"frameElements":[{"name":"Building_part","spans":[{"start":32,"end":33,"text":"cells"}]}]}]}],"tokens":["Constitutive","epidermal","growth","factor","receptor","-LRB-","EGFR","-RRB-","and","nuclear","factor","kappa","b","-LRB-","NF-kappa","B","-RRB-","activities","are","seen","in","multiple","solid","tumors","and","combine","to","provide","oncogenic","signals","to","cancer","cells","."]}
{"frames":[{"target":{"name":"Roadways","spans":[{"start":4,"end":5,"text":"pathways"}]},"annotationSets":[{"rank":0,"score":73.2845398612125,"frameElements":[{"name":"Roadway","spans":[{"start":4,"end":5,"text":"pathways"}]}]}]},{"target":{"name":"Cognitive_connection","spans":[{"start":6,"end":7,"text":"connected"}]},"annotationSets":[{"rank":0,"score":31.18969707787852,"frameElements":[{"name":"Concept_1","spans":[{"start":2,"end":5,"text":"these oncogenic pathways"}]}]}]},{"target":{"name":"Importance","spans":[{"start":8,"end":9,"text":"crucial"}]},"annotationSets":[{"rank":0,"score":42.334683831460794,"frameElements":[{"name":"Undertaking","spans":[{"start":10,"end":22,"text":"given their role in intrinsic or acquired resistance to targeted anticancer therapies"}]}]}]},{"target":{"name":"Giving","spans":[{"start":10,"end":11,"text":"given"}]},"annotationSets":[{"rank":0,"score":52.13806119718887,"frameElements":[{"name":"Theme","spans":[{"start":11,"end":22,"text":"their role in intrinsic or acquired resistance to targeted anticancer therapies"}]}]}]},{"target":{"name":"Performers_and_roles","spans":[{"start":12,"end":13,"text":"role"}]},"annotationSets":[{"rank":0,"score":43.977002980161075,"frameElements":[{"name":"Performer","spans":[{"start":11,"end":12,"text":"their"}]}]}]},{"target":{"name":"Getting","spans":[{"start":16,"end":17,"text":"acquired"}]},"annotationSets":[{"rank":0,"score":48.74231845209531,"frameElements":[{"name":"Theme","spans":[{"start":17,"end":18,"text":"resistance"}]}]}]},{"target":{"name":"Cure","spans":[{"start":21,"end":22,"text":"therapies"}]},"annotationSets":[{"rank":0,"score":46.3814611622019,"frameElements":[]}]}],"tokens":["Understanding","how","these","oncogenic","pathways","are","connected","is","crucial",",","given","their","role","in","intrinsic","or","acquired","resistance","to","targeted","anticancer","therapies","."]}
{"frames":[{"target":{"name":"Means","spans":[{"start":3,"end":4,"text":"mechanisms"}]},"annotationSets":[{"rank":0,"score":20.53004640124273,"frameElements":[{"name":"Agent","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Means","spans":[{"start":4,"end":20,"text":"by which both EGFR- and NF-kappa B-dependent pathways establish positive loops to increase their oncogenic potential"}]},{"name":"Descriptor","spans":[{"start":2,"end":3,"text":"molecular"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":6,"end":7,"text":"both"}]},"annotationSets":[{"rank":0,"score":22.419473902624613,"frameElements":[{"name":"Quantity","spans":[{"start":6,"end":7,"text":"both"}]},{"name":"Individuals","spans":[{"start":7,"end":8,"text":"EGFR-"}]}]}]},{"target":{"name":"Roadways","spans":[{"start":11,"end":12,"text":"pathways"}]},"annotationSets":[{"rank":0,"score":66.55086208417057,"frameElements":[{"name":"Roadway","spans":[{"start":11,"end":12,"text":"pathways"}]}]}]},{"target":{"name":"Intentionally_create","spans":[{"start":12,"end":13,"text":"establish"}]},"annotationSets":[{"rank":0,"score":54.33400711968786,"frameElements":[{"name":"Creator","spans":[{"start":6,"end":12,"text":"both EGFR- and NF-kappa B-dependent pathways"}]},{"name":"Created_entity","spans":[{"start":13,"end":15,"text":"positive loops"}]},{"name":"Purpose","spans":[{"start":15,"end":20,"text":"to increase their oncogenic potential"}]}]}]},{"target":{"name":"Certainty","spans":[{"start":13,"end":14,"text":"positive"}]},"annotationSets":[{"rank":0,"score":35.622794154664135,"frameElements":[{"name":"Content","spans":[{"start":14,"end":15,"text":"loops"}]}]}]},{"target":{"name":"Cause_change_of_position_on_a_scale","spans":[{"start":16,"end":17,"text":"increase"}]},"annotationSets":[{"rank":0,"score":62.40904928535291,"frameElements":[]}]},{"target":{"name":"Capability","spans":[{"start":19,"end":20,"text":"potential"}]},"annotationSets":[{"rank":0,"score":40.301417074966345,"frameElements":[{"name":"Event","spans":[{"start":18,"end":19,"text":"oncogenic"}]},{"name":"Entity","spans":[{"start":17,"end":18,"text":"their"}]}]}]}],"tokens":["We","review","molecular","mechanisms","by","which","both","EGFR-","and","NF-kappa","B-dependent","pathways","establish","positive","loops","to","increase","their","oncogenic","potential","."]}
{"frames":[{"target":{"name":"Communicate_categorization","spans":[{"start":2,"end":3,"text":"describe"}]},"annotationSets":[{"rank":0,"score":39.42631083630808,"frameElements":[{"name":"Speaker","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Item","spans":[{"start":3,"end":11,"text":"how NF-kappa B promotes resistance to EGFR inhibitors"}]}]}]},{"target":{"name":"Cause_change_of_position_on_a_scale","spans":[{"start":6,"end":7,"text":"promotes"}]},"annotationSets":[{"rank":0,"score":60.61855751858044,"frameElements":[{"name":"Item","spans":[{"start":7,"end":11,"text":"resistance to EGFR inhibitors"}]},{"name":"Agent","spans":[{"start":4,"end":6,"text":"NF-kappa B"}]}]}]}],"tokens":["We","also","describe","how","NF-kappa","B","promotes","resistance","to","EGFR","inhibitors","."]}
